Escitalopram + Clonazepam 

Escitalopram

• Demonstrates 74.1% efficacy with a good safety profile in patients with depression with therapy for 8 weeks!

• Demonstrates more effective & cost-saving therapy in the treatment of major depressive disorder in comparison to venlafaxine XR therapy

Clonazepam

•Demonstrates a high efficacy in the treatment of depression due to its longer half life & easier for discontinuation due to its minimal withdrawal symptoms in comparison to other anti-depressive agents

• Effective therapy for the augmentation of ongoing antidepressant treatment in prolonged depressive patients with suboptimal improvement